The board meeting for Vivos Therapeutics Inc is scheduled for today, for the purpose of Vivos Therapeutics Inc First Quarter Earnings Results for 2026See details
Vivos Therapeutics Inc has a share price target of US$ 2, revenue growth forecast of 33.4%, and profit growth estimate of 8.1% for FY26, based on top 3 analyst calls.